BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1
120 results:

  • 1. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
    Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Effects of Fucoidan Derived from
    Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ghana 3D Telemedicine International MDT: A proof-of-concept study.
    Lo S; Rose A; Fowers S; Darko K; Britto A; Spina T; Ankrah L; Godonu A; Ntreh D; Lalwani R; Graham C; Tittsworth D; McIntyre A; O'Dowd C; Watson S; Maguire R; Hoak A; Ampomah O; Cutler B;
    J Plast Reconstr Aesthet Surg; 2024 Jan; 88():425-435. PubMed ID: 38091684
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk Factors for Treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent Cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
    Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
    J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
    [No Abstract]    [Full Text] [Related]  

  • 5. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
    Lohberger B; Kaltenegger H; Eck N; Glänzer D; Leithner A; Kretschmer N
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958891
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Efficacy and safety of Anlotinib in the treatment of advanced sarcoma].
    Yan Q; Yao WT; Du XH; Guo LY; Fan YC
    Zhonghua Zhong Liu Za Zhi; 2023 Oct; 45(10):904-910. PubMed ID: 37875427
    [No Abstract]    [Full Text] [Related]  

  • 7. Pot1b -/- tumors activate G-quadruplex-induced DNA damage to promote telomere hyper-elongation.
    Takasugi T; Gu P; Liang F; Staco I; Chang S
    Nucleic Acids Res; 2023 Sep; 51(17):9227-9247. PubMed ID: 37560909
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Is Dissection and Preservation of Adherent Popliteal Vessels From a Posterior Soft Tissue Mass Associated With a Higher Proportion of Local Recurrence in Patients With a Distal Femoral Osteosarcoma?
    Ebeid W; Elghoneimy A; Abousenna W
    Clin Orthop Relat Res; 2023 Nov; 481(11):2167-2176. PubMed ID: 37527334
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
    Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tandem mass tag (TMT) quantitative protein analysis-based proteomics and parallel reaction monitoring (PRM) validation revealed that MST4 accelerates osteosarcoma proliferation by increasing MRC2 activity.
    Liu Y; Zhang X; Ren X; Sun J; Wen Y; Guo Z; Ma Q
    Mol Carcinog; 2023 Sep; 62(9):1338-1354. PubMed ID: 37378424
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The FBXO32/atr/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
    Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma.
    Knipprath-Mészáros AM; Tozzi A; Butenschön A; Reina H; Schoetzau A; Montavon C; Heinzelmann-Schwarz V; Manegold-Brauer G
    Gynecol Oncol; 2023 Jul; 174():182-189. PubMed ID: 37210928
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Synergistic anticancer activity of combined atr and ribonucleotide reductase inhibition in Ewing's sarcoma cells.
    Sturm MJ; Henao-Restrepo JA; Becker S; Proquitté H; Beck JF; Sonnemann J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8605-8617. PubMed ID: 37097390
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.
    Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M
    Front Immunol; 2023; 14():1150588. PubMed ID: 37090691
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.
    Forker LJ; Bibby B; Yang L; Lane B; Irlam J; Mistry H; Khan M; Valentine H; Wylie J; Shenjere P; Leahy M; Gaunt P; Billingham L; Seddon BM; Grimer R; Robinson M; Choudhury A; West C
    Br J Cancer; 2023 Jun; 128(12):2307-2317. PubMed ID: 37085598
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evaluation of vincristine-induced peripheral neuropathy in children with cancer: Turkish validity and reliability study.
    Özdemir B; Gerçeker GÖ; Özdemir EZ; Yildirim BG; Ören H; Yiş U; Günay Ç; Thomas GÖ
    J Pediatr Nurs; 2023; 72():185-190. PubMed ID: 37076371
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A review of recent advances in the novel therapeutic targets and immunotherapy for lung cancer.
    Khadela A; Postwala H; Rana D; Dave H; Ranch K; Boddu SHS
    Med Oncol; 2023 Apr; 40(5):152. PubMed ID: 37071269
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
    McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
    Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Amputation surgery associated with shortened survival in patients with localized soft tissue sarcoma.
    Matsuoka M; Onodera T; Yokota I; Iwasaki K; Hishimura R; Suzuki Y; Hamasaki M; Iwata A; Kondo E; Iwasaki N
    J Orthop Sci; 2024 Mar; 29(2):637-645. PubMed ID: 36931976
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sarcoma brain metastases: Tertiary cancer center experience.
    Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.